Skip Navigation

A Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients with Advanced Renal Cell Carcinoma with Bone Metastasis RadiCal

Brief Summary

Type:
Kidney

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT04071223

Study #:
STUDY00145220

Start Date:
Apr 21, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04071223

View Complete Trial Details & Eligibility at ClinicalTrials.gov